RxDoctor Payments Data

Joseph Rizzo, MD

Ophthalmology · Boston, MANPI 1235109414

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $7,134 of the $9,588 with a category attached, or 74.4%. Dompe Farmaceutici S.p.a. accounts for 74.5% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $8,168, more than ten times the $64 reported in 2019.

$9,588in general payments, 2019–2025

Across 54 payments — averaging $177.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Dompe Farmaceutici S.p.a.$7K
  • Amgen$2K
  • E.r. Squibb & Sons, L.L.C.$119
  • AstraZeneca$115
  • Alcon$64

What the payments were for

  • Consulting fees$7,13474%
  • Food & beverage$2,45426%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Dompe Farmaceutici S.p.a.5$7,141
Amgen(2 entities)46$2,149
E.r. Squibb & Sons, L.L.C.1$119
AstraZeneca1$115
Alcon1$64

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,588 in reported general payments places this provider in the 85th percentile of 653 ophthalmology providers in Massachusetts.

See all ophthalmology providers in Massachusetts →

Medicare billing

Part B allowed, 2024
$70,425
Medicare patients
334
Services billed
909

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other ophthalmology in Boston

See the full list for Massachusetts →

Where these figures come from

Is this you, or does something look wrong? →